Donald W. Reynolds National Center for Business Journalism

Merck may have scored a victory in its second Vioxx trial this week. But business reporters kept the game in check for readers across the country. » More

Lessons Stress Need for Skepticism in Drug Coverage

Rather than healthy speculation, temperate glorification seems to be the theme of how a majority of reporters covered blockbuster drugs recently linked to serious health concerns. » More

Consolidation Leaves Health Care Information at a Premium

Controversial health care consolidation is an issue that business reporters can expect to see often in the future. » More

Technology and Research Critical on the Pharmaceutical Beat

The pharmaceutical industry has evolved in recent years into one of the most crucial beats on the business desk. » More

Open the Black Box When Covering the Drug and Biotechnology Industries

Cutting-edge coverage of the drug and biotechnology industries can attract readers who might otherwise skip over the business section. » More